Xponance’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Buy	30,519 +6,231	+26%	+$19.9K	﹤0.01%	1567
2025 Q4	$66.3K	Buy	24,288 +3,950	+19%	+$9.14K	﹤0.01%	1502
2025 Q3	$44.1K	Buy	20,338 +398	+2%	+$940	﹤0.01%	1495
2025 Q2	$34.3K	Sell	19,940 -787	-4%	-$1.96K	﹤0.01%	1476
2025 Q1	$69K	Buy	20,727 +1,120	+6%	+$5.78K	﹤0.01%	1377
2024 Q4	$145K	Buy	19,607 +3,066	+19%	+$28.4K	﹤0.01%	1326
2024 Q3	$155K	Buy	16,541 +262	+2%	+$2.48K	﹤0.01%	1275
2024 Q2	$131K	Buy	16,279 +1,873	+13%	+$20.1K	﹤0.01%	1226
2024 Q1	$213K	Buy	14,406 +557	+4%	+$6.48K	﹤0.01%	1170
2023 Q4	$113K	Buy	13,849 +390	+3%	+$2.04K	﹤0.01%	1203
2023 Q3	$61.2K	Buy	13,459 +1,215	+10%	+$7.93K	﹤0.01%	1192
2023 Q2	$86.2K	Buy	+12,244	New	+$87.6K	﹤0.01%	1202
2021 Q2	–	Sell	-14,531	Closed	-$460K	–	1256
2021 Q1	$460K	Buy	14,531 +195	+1%	+$8.08K	0.01%	814
2020 Q4	$665K	Sell	14,336 -61	-0.4%	-$2.42K	0.01%	620
2020 Q3	$474K	Buy	14,397 +72	+0.5%	+$2.21K	0.01%	666
2020 Q2	$393K	Buy	+14,325	New	+$471K	0.01%	717